今开:2.02 | 昨收:2.0 |
最高:2.02 | 最低:1.93 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.4232996E7 |
Alterity(ATHE)04-29 18:25
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036798 Act: 34 Size: 37 KB 网页链接查看全文
Alterity(ATHE)04-17 18:05
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-033566 Act: 34 Size: 58 KB 网页链接查看全文
Alterity(ATHE)05-09 18:05
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040963 Act: 34 Size: 37 KB 网页链接查看全文
Alterity(ATHE)03-04 21:05
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-019255 Act: 34 Size: 42 KB 网页链接查看全文
Alterity(ATHE)05-23 18:05
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046048 Act: 34 Size: 44 KB 网页链接查看全文
Alterity(ATHE)03-26 20:05
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-025771 Act: 34 Size: 29 KB 网页链接查看全文
Alterity(ATHE)04-15 20:05
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032741 Act: 34 Size: 58 KB 网页链接查看全文
Alterity(ATHE)03-15 18:15
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-022723 Act: 34 Size: 1 MB 网页链接查看全文
Alterity(ATHE)03-04 21:05
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-019252 Act: 34 Size: 62 KB 网页链接查看全文
Linktu2021-02-28 09:21
$Alterity医疗(ATHE)$ 替代性疾病的主要候选药物ATH434(以前称为PBT434)是新一代小分子药物中的第一个,旨在抑制与神经退行性病变有关的病理蛋白的聚集。ATH434已显示可通过在大脑中重新分配不稳定的铁减少疾病动物模型中α-突触核蛋白和tau蛋白的异常积累。这样,它就有可能治疗帕金森氏病和非...查看全文
Linktu2021-02-11 07:50
$Alterity医疗(ATHE)$ 获得Michael J. Fox基金会的拨款,用于帕金森氏症的研究基于脑铁成像,确定针对帕金森氏病(PD)的主要药物候选药物ATH434的最佳剂量。查看全文
格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046048 Act: 34 Size: 44 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040963 Act: 34 Size: 37 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-037462 Act: 34 Size: 210 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036798 Act: 34 Size: 37 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-036801 Act: 34 Size: 53 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-033566 Act: 34 Size: 58 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032741 Act: 34 Size: 58 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032316 Act: 34 Size: 317 KB 网页链接
$Alterity(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032317 Act: 34 Size: 215 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-025771 Act: 34 Size: 29 KB 网页链接